DF
SAGE

Donoghue Forlines’s Sage Therapeutics SAGE Stock Holding History

Donoghue Forlines’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,780
Closed -$272K – 239
2021
Q2 		$272K Buy
4,780
+705
+17% +$40.1K 0.05% 198
2021
Q1 		$305K Buy
+4,075
New +$305K 0.06% 205